Kazuhiro Sonomura Selected Research

palmitoleic acid

5/2023

Evaluation of elevated plasma fatty acids as relevant factors for adult-onset asthma: The Nagahama Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuhiro Sonomura Research Topics

Disease

4	Neoplasms (Cancer) 12/2022 - 01/2017
3	Chronic Renal Insufficiency 01/2023 - 09/2009
3	Fibrosis (Cirrhosis) 03/2012 - 01/2009
2	Asthma (Bronchial Asthma) 05/2023 - 01/2023
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2020
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 01/2023 - 03/2004
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 01/2020
2	Peritoneal Fibrosis 01/2009 - 01/2009
2	Infections 12/2007 - 03/2004
1	Rheumatoid Arthritis 11/2023
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 11/2023
1	Hodgkin Disease (Hodgkin's Disease) 11/2023
1	Breast Neoplasms (Breast Cancer) 10/2023
1	Triple Negative Breast Neoplasms 10/2023
1	Carcinogenesis 10/2023
1	Dehydration (Water Stress) 09/2023
1	Obesity 05/2023
1	Paraproteinemias (Monoclonal Gammopathy) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Gastroesophageal Reflux (GERD) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Chronic Disease (Chronic Diseases) 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Cough 01/2023
1	Insulin Resistance 01/2020
1	Glucose Intolerance 01/2020
1	Weight Loss (Weight Reduction) 01/2019
1	Proteinuria 01/2019
1	Taste Disorders (Taste Disorder) 09/2009
1	Hypertension (High Blood Pressure) 09/2009
1	Peritonitis 12/2007
1	Pancreatitis 03/2004
1	Lupus Nephritis 03/2004

Drug/Important Bio-Agent (IBA)

2	LipidsIBA 10/2023 - 05/2023
2	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2020
2	Triglycerides (Triacylglycerol)IBA 10/2023 - 01/2020
2	LigandsIBA 12/2022 - 01/2020
2	NivolumabIBA 12/2022 - 01/2020
2	SaltsIBA 01/2019 - 09/2009
2	AldosteroneIBA 01/2009 - 01/2009
1	Methotrexate (Mexate)FDA LinkGeneric 11/2023
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 10/2023
1	CeramidesIBA 10/2023
1	SphingomyelinsIBA 10/2023
1	Sucrose (Saccharose)IBA 10/2023
1	PhosphatidylserinesIBA 10/2023
1	Phosphatidylethanolamines (Cephalins)IBA 10/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 10/2023
1	HCEIBA 09/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 05/2023
1	palmitoleic acidIBA 05/2023
1	Oleic Acid (Oleate)IBA 05/2023
1	Nonesterified Fatty Acids (NEFA)IBA 05/2023
1	FructoseIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	4-cresol sulfateIBA 01/2023
1	Citric Acid (Citrate)FDA LinkGeneric 01/2023
1	BezafibrateIBA 12/2022
1	4-cresol (p-cresol)IBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2012
1	Phosphotransferases (Kinase)IBA 03/2012
1	SodiumIBA 09/2009
1	ZincIBA 09/2009
1	A-factor (Streptomyces)IBA 09/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2007
1	TinIBA 03/2004

Therapy/Procedure

4	Immunotherapy 12/2022 - 01/2017
3	Therapeutics 01/2020 - 12/2007
2	Peritoneal Dialysis 01/2009 - 12/2007
1	Continuous Positive Airway Pressure 01/2023
1	Aftercare (After-Treatment) 01/2020
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 01/2019
1	Continuous Ambulatory Peritoneal Dialysis (CAPD) 01/2009
1	Catheters 12/2007